
GlaxoSmithKline PLC
LSE:GSK

Intrinsic Value
The intrinsic value of one
GSK
stock under the Base Case scenario is
1 663.39
GBX.
Compared to the current market price of 1 294 GBX,
GlaxoSmithKline PLC
is
Undervalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
GlaxoSmithKline PLC
Fundamental Analysis


Revenue & Expenses Breakdown
GlaxoSmithKline PLC
Balance Sheet Decomposition
GlaxoSmithKline PLC
Current Assets | 17B |
Cash & Short-Term Investments | 3.9B |
Receivables | 7.3B |
Other Current Assets | 5.8B |
Non-Current Assets | 42.5B |
Long-Term Investments | 1.2B |
PP&E | 10.1B |
Intangibles | 22.5B |
Other Non-Current Assets | 8.7B |
Free Cash Flow Analysis
GlaxoSmithKline PLC
GBP | |
Free Cash Flow | GBP |
Earnings Waterfall
GlaxoSmithKline PLC
Revenue
|
31.4B
GBP
|
Cost of Revenue
|
-8.8B
GBP
|
Gross Profit
|
22.6B
GBP
|
Operating Expenses
|
-14.4B
GBP
|
Operating Income
|
8.1B
GBP
|
Other Expenses
|
-5.6B
GBP
|
Net Income
|
2.6B
GBP
|
GSK Profitability Score
Profitability Due Diligence
GlaxoSmithKline PLC's profitability score is 69/100. The higher the profitability score, the more profitable the company is.

Score
GlaxoSmithKline PLC's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
GSK Solvency Score
Solvency Due Diligence
GlaxoSmithKline PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Score
GlaxoSmithKline PLC's solvency score is 46/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GSK Price Targets Summary
GlaxoSmithKline PLC
According to Wall Street analysts, the average 1-year price target for
GSK
is 1 685.95 GBX
with a low forecast of 1 201.9 GBX and a high forecast of 2 782.5 GBX.
Dividends
Current shareholder yield for GSK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
GSK
stock under the Base Case scenario is
1 663.39
GBX.
Compared to the current market price of 1 294 GBX,
GlaxoSmithKline PLC
is
Undervalued by 22%.